STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS LawBusiness Wire • 11/07/26
STVN INVESTOR ALERT: Investigation of Stevanato Group S.p.A. Announced by Holzer & Holzer, LLCGlobeNewsWire • 11/04/26
Lost Money on Stevanato Group S.p.A. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.57% Share Price DropBusiness Wire • 11/04/26
Did You Lose Money on Stevanato Group S.p.A. Stock? The Law Offices of Howard G.Business Wire • 11/04/26
Stevanato Group (STVN) Shareholder Investigation Following Stock Decline – Kehoe Law Firm, P.C.GlobeNewsWire • 11/04/26
Stevanato Group S.p.A. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Stevanato Group S.p.A.PRNewsWire • 11/03/26
Stevanato Group (STVN) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/03/26
Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026Business Wire • 11/03/26
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System SelectionBusiness Wire • 10/27/26
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026Business Wire • 10/20/26
Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
Is Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 08/05/26
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026Business Wire • 08/04/26
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European CountriesBusiness Wire • 07/30/26